Yazar "Capuk, Huseyin" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Frequency of University Students' Use of Addictive Substances and Attitudes Toward Addictive Substances
    (Turkish Green Crescent Soc, 2022) Capuk, Huseyin; Aylaz, Rukuye
    This study aims to assess the level of knowledge, frequency of use, and attitudes toward addictive substances among university students. This descriptive study was conducted between December 2020 and May 2021. The sample of the research consists of 531 students who volunteered to participate in the research via Google forms. The statistical significance of the data was evaluated at the p.05 level. To analyze the data, percentage, mean, one-way analysis of variance, cross-tabulations, and Kruskal-Wallis test were used. In terms of students' knowledge about addictive substances, it was found that 34.7% of students knew about marijuana, and 30.3% knew about heroin. It was found that 46.4% of students who tried to use substances for the first time were volatile, and 39.3% of them used marijuana. A statistically significant difference was found between the presence of students in an environment where addictive substances were used and their absence in terms of substance use tendency (p < .05). A more significant difference was found between the presence and absence of substance users in the family concerning substance use (p < .05). It was recommended to conduct awareness and education activities in family, friends, and universities in order to prevent substance use and addiction.
  • Küçük Resim Yok
    Öğe
    The Impact of Transtheoretical Model-Based Motivational Interviewing on Self-Efficacy and Adherence to Treatment in Hemodialysis Patients
    (Wiley, 2025) Capuk, Huseyin; Aylaz, Rukuye
    Aim(s)The aim of this study was to evaluate the impact of Transtheoretical Model-based Motivational Interviewing on self-efficacy and illness adjustment in hemodialysis patients. BackgroundHemodialysis patients often face challenges in adhering to dietary, fluid, and medication guidelines due to the lengthy nature of the dialysis sessions and various associated restrictions. MethodsThis study was conducted between June 2022 and March 2023 at hemodialysis centers in eastern Turkey. It included 30 patients in the experimental group and 30 in the control group. The experimental group received six sessions of Transtheoretical Model-based motivational interviewing, while the control group received no intervention. This pretest-posttest randomized controlled trial was registered in the Clinical Trials Registry (NCT06706843). ResultsThe results indicated a significant improvement in GSES scores. A significant difference was found between the groups in pre-test scores (p < 0.05), and a statistically significant difference was also observed in Posttest scores (p < 0.05). Within-group comparisons revealed significant differences between pretest and posttest scores for the experimental group (p < 0.05). There was a significant difference between pre-test and Posttest scores in the control group (p < 0.05). In the SDBM-NOS showed a significant difference between the experimental and control groups in the dietary adherence subscale at Posttest (p < 0.05), but no significant difference was found in the other subscales. In the experimental group, a significant improvement was observed between pre-test and Posttest in terms of total ESRD-AS score, fluid compliance and dietary compliance (p < 0.05). In the control group, no significant difference was found for any variable (p > 0.05). A significant negative correlation was found between GSES and ESRD-AS. ConclusionIn conclusion, Transtheoretical Model-based Motivational Interviewing was found to significantly improve treatment adherence and self-efficacy in chronic hemodialysis patients, contributing to better illness adjustment. Trial Registration: identifier: NCT06706843. ConclusionIn conclusion, Transtheoretical Model-based Motivational Interviewing was found to significantly improve treatment adherence and self-efficacy in chronic hemodialysis patients, contributing to better illness adjustment. Trial Registration: identifier: NCT06706843.